Last reviewed · How we verify
NCT06795633: RGYBBP
The Impact of a Holistic Care Program for High-Risk Pregnancies on Stress and Mental Health
NA trial testing Holistic Care Program for High-Risk Pregnancies in High-risk Pregnancy in 100 participants. Completed in 30 October 2024.
14 June 2024
Quick facts
| Lead sponsor | Uskudar University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 100 |
| Start date | 1 April 2024 |
| Primary completion | 14 June 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 2 locations across Turkey (Türkiye) |
Drugs / interventions tested
- Holistic Care Program for High-Risk Pregnancies
Conditions studied
- High-risk Pregnancy — all drugs for High-risk Pregnancy →
- Holistic Care — all drugs for Holistic Care →
- Stress — all drugs for Stress →
- Prenatal Stress — all drugs for Prenatal Stress →
Sponsor
Uskudar University
Who can join
18 and older, female only, with High-risk Pregnancy or Holistic Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the effects of the Holistic Care Program for High-Risk Pregnancies on the stress levels and mental health of pregnant women. Within this framework, the study seeks to examine the potential of the holistic care program to strengthen stress coping mechanisms, positively influence mental health, and enhance general health awareness among high-risk pregnant women. The study was conducted using a randomized controlled trial design between April 1, 2024, and December 31, 2024, at a maternity hospital in Istanbul. A total of 100 high-risk pregnant women were randomized into two groups: 50 participants were assigned to the group receiving the holistic care program along with routine midwifery care (intervention), and 50 were assigned to the group receiving only routine midwifery care (control). The Holistic Care Program for High-Risk Pregnancies consists of three sessions: Physiological Information and Preparation for High-Risk Pregnancy, Psychological Support and Preparation, and Creative Practices and Final Evaluation. Research data were collected using five forms: Informed Consent Form, Demographic Information Form, Perceived Stress Scale for High-Risk Pregnancies Based on Neuman Systems Model, Brief Symptom Inventory, and Holistic Care Program Evaluation Form for High-Risk Pregnancies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06795633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for High-risk Pregnancy
Currently open trials in the same condition.
- NCT07281339 — Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women · NA · recruiting
- NCT06932250 — Leg Heating in Pregnant Women With Obesity · NA · recruiting
Other Uskudar University trials
Trials by the same sponsor.
- NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
- NCT07498088 — THE EFFECT OF HAPTONOMY PRACTICE ON PREGNANT WOMEN WITH A HISTORY OF ABORTION. · NA · not yet recruiting
- NCT07447180 — The Effectiveness of Exercise Combined With Ergonomics Training for Musculoskeletal Pain Seen in Pastry Chefs · NA · recruiting
- NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
- NCT07498114 — Association Between Fatigue Severity and Health-Related Quality of Life in Individuals With Stroke · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06795633 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uskudar University
- Last refreshed: 11 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06795633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing